Business
Issue of Convertible Loan Notes
Aterian plc has issued £150,000 of zero-coupon convertible loan notes maturing on 31/12/2027 to a longstanding shareholder, which are mandatorily convertible into ordinary shares at 25 pence per share. Subscribers also received 300,000 warrants exercisable at 32.5 pence, with a maturity date of 15 February 2028 and a call feature if the share price exceeds 50 pence for three consecutive days. The company plans to use the net proceeds to support its trading operations, particularly given the recent significant increase in China Tantalum Concentrate pricing from US$101/lb to US$212/mtu since year-end 2025. Disclaimer*
About this update from Aterian Plc
[{"type":"text","content":"\n\n12 March 2026\n \nAterian plc\n(\"Aterian\" or the \"Company\" or the \"Group\")\n \nIssue of Convertible Loan Notes\n \nAterian Plc (LSE: ATN), the critical metal-focused exploration and development company, announces that it has issued £150,000 of convertible loan notes (\"CLNs\") with a maturity date of 31/12/2027 to a longstanding shareholder.\n \nThe CLNs are mandatorily convertible into Ordinary Shares of 10 pence each in the Company (\"Ordinary Shares\") at a price of 25 pence per Ordinary Share on or before the maturity date, have zero coupon, and are redeemable by the Company at par at any time prior to their maturity date, subject to notice. This redemption feature provides the Company with the flexibility and optionality to repay the notes in cash should operational cash flows from trading activities continue to remain positive, thereby potentially reducing and/or eliminating dilution to shareholders from the capital raise.\n \nSubscribers to the CLN will also receive 300,000 warrants (the \"Warrants\"), or effectively 50% warrant coverage, with each Warrant exercisable at a strike price of 32.5 pence per Ordinary Share. The Warrants will have a maturity date of 15 February 2028 and a call feature should the Company's closing mid-price exceed 50 pence for three consecutive trading days.\n \nThe Company intends to utilise the net proceeds from the CLN issue to support the continued development of its trading operations, following the increase in pricing for China Tantalum Concentrate 30% CIF, which has risen from US$101/lb to US$212/mtu since year-end 2025.\nCharles Bray, Executive Chairman of Aterian, commented:\n\"This capital injection strengthens the Company's balance sheet and provides additional financial flexibility as we continue to advance our trading initiatives. This redemption feature provides Aterian with cheap optionality and the additional funds to acquire materials, which have more than doubled in price over the past 10 weeks[1]. We remain focused on building value through disciplined capital allocation and by progressing our projects across Africa. We see dramatic moves in commodity demand and pricing and are focused on providing the market with responsibly sourced critical minerals.\"\nFurther announcements will be made as appropriate.\n- ENDS -\n \nThis announce...